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Abstract The 2-C-methyl-D-erythritol 4-phosphate (MEP)
pathway for isoprenoid biosynthesis is essential in most
eubacteria and plants and has remarkable biotechnological
interest. However, only the first steps of this pathway have been
determined. Using bioinformatic and genetic approaches, we
have identified gcpE as a novel gene of the MEP pathway. The
distribution of this gene in bacteria and plants strictly parallels
that of the gene encoding 1-deoxy-D-xylulose 5-phosphate
reductoisomerase, which catalyses the first committed step of
the MEP pathway. Our data demonstrate that the gcpE gene is
essential for the MEP pathway in Escherichia coli and indicate
that this gene is required for the trunk line of the isoprenoid
biosynthetic route. ß 2001 Federation of European Biochemi-
cal Societies. Published by Elsevier Science B.V. All rights
reserved.
Key words: Isoprenoid biosynthesis ;
2-C-methyl-D-erythritol 4-phosphate pathway; GcpE ;
Mevalonic acid
1. Introduction
Isoprenoids are the most structurally diverse family of com-
pounds found in nature. More than 30 000 isoprenoid mole-
cules are known to date [1]. Many isoprenoids have biotech-
nological applications as drugs, £avours, pigments, perfumes
or agrochemicals. In living beings, isoprenoids have important
roles in processes as diverse as electron transport, reproduc-
tion, growth regulation, signal transduction and defence. Iso-
prenoid biosynthesis is essential in all organisms. In Escheri-
chia coli, for instance, the isoprenoids ubiquinone and
bactoprenol are required, respectively, for respiration and
cell wall biosynthesis. In spite of the structural and functional
diversity of isoprenoids, all derive from the ¢ve-carbon iso-
mers isopentenyl diphosphate (IPP) and dimethylallyl diphos-
phate (DMAPP) which, altogether, constitute the basic build-
ing block of isoprenoids.
Two alternative pathways for the synthesis of IPP and
DMAPP exist in nature: the well known mevalonate (MVA)
pathway and the recently discovered 2-C-methyl-D-erythritol
4-phosphate (MEP) pathway [2^4]. Most eubacteria, including
E. coli, have only the MEP pathway. The initial step of this
pathway involves the formation of 1-deoxy-D-xylulose 5-phos-
phate (DXP) from pyruvate and glyceraldehyde 3-phosphate
(Fig. 1). This reaction is catalysed by 1-deoxy-D-xylulose
5-phosphate synthase (DXS), encoded by the dxs gene in
E. coli [5,6]. DXP can be converted to isoprenoids, but also
to thiamine and pyridoxal. Therefore, the following reaction,
consisting in the conversion of DXP to MEP, is most prob-
ably the ¢rst committed step of the pathway. This reaction is
catalysed by 1-deoxy-D-xylulose 5-phosphate reductoisomer-
ase (DXR) which is encoded by the dxr gene [7]. In the next
step, the ygbP gene product mediates the condensation of
MEP with CTP to form 4-diphosphocytidyl-2-C-methyl-D-er-
ythritol (CDP-ME) [8,9]. CDP-ME is then phosphorylated by
the ychB gene product to 4-diphosphocytidyl-2-C-methyl-D-
erythritol 2-phosphate (CDP-ME2P) [10,11]. The ygbB gene
product catalyses the elimination of the CMP moiety from
CDP-ME2P to yield 2-C-methyl-D-erythritol 2,4-cyclodiphos-
phate (ME-2,4cPP) [12,13] which is the last intermediate of
the pathway known to date. Labelling studies indicated that,
in E. coli, IPP and DMAPP are synthesised from MEP by
routes that separate at some point [14^16]. Genetic studies
con¢rmed the operation of separate routes for the synthesis
of IPP and DMAPP in E. coli [17] and showed that the re-
actions catalysed by the ygbP, ychB and ygbB gene products
belong to the trunk line of the pathway [18] (Fig. 1). These
evidences led to conclude that the branching of the MEP
pathway occurs after ME2,4-cPP [18].
To identify novel genes of the MEP pathway, we engineered
E. coli for the synthesis of IPP and DMAPP from MVA [18]
(Fig. 1). The presence of this engineered route for the produc-
tion of isoprenoid units in the bacterium allows the rescue of
otherwise lethal mutants of the MEP pathway. The growth of
these mutants is dependent on the exogenous supply of MVA.
In the present work, we use this system to demonstrate that
the gcpE gene, which is broadly distributed in eubacteria and
plants, is essential for the operation of the MEP pathway in
E. coli.
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2. Materials and methods
2.1. Deletion of the gcpE gene in strain EcAB3-1
Strain EcAB3-1 is a recD mutant host which allows e⁄cient recom-
bination of linear DNA with homologous sequences in the chromo-
some (Table 1). To delete the gcpE coding sequence in the E. coli
genome, a recombination construct was prepared in which the CAT
gene was cloned between the gcpE £anking regions (Fig. 2). Substi-
tution of the CAT gene for the gcpE coding sequence in the genome
was selected by chloramphenicol resistance.
Four PCR reactions were necessary to prepare the recombination
construct. First, a genomic region of 3231 bp, encompassing the gcpE
coding sequence (1116 bp), together with the corresponding £anking
regions, was ampli¢ed using genomic DNA from strain MC4100 [19]
as template and the oligonucleotides 1PE and 4PE as primers (Table
2). Next, the PCR product obtained was used as template to amplify
the gcpE £anking regions. Primers 1PE and 22PE were used to am-
plify the 5P £anking region. In this PCR, primer 22PE generated a
SmaI restriction site. Primers 3PE and 4PE were used to amplify the
3P £anking region. In this PCR, primer 3PE generated a PmeI restric-
tion site. The PCR product corresponding to the 3P £anking region
(1061 bp) was cloned in the SmaI restriction site of plasmid pBlue-
script SK+. The plasmid obtained was named GC3. Subsequently, the
PCR product corresponding to the 5P £anking region (1102 bp) was
cloned in the PmeI restriction site of plasmid GC3. The plasmid con-
taining the two £anking regions was named GC53. The relative ori-
entation of the 3P and 5P £anking regions in this plasmid was the same
as in the E. coli genome. Finally, the CAT gene was ampli¢ed by PCR
using plasmid pCAT19 as template [20] and the oligonucleotides
CAT1 and CAT4 as primers. The PCR product (960 bp) was cloned
in the SmaI restriction site of plasmid GC53. The construct obtained
was named GC5CAT3. In this construct, the CAT gene had the same
orientation as the coding sequence of the gcpE gene previously de-
leted. Since the CAT gene contained its own promoter elements and
coding sequence, but did not contain any transcription termination
signal, no polar e¡ect downstream of the gcpE gene was expected.
Plasmid containing the construct GC5CAT3 was digested with Hin-
dIII, XbaI and XhoI restriction enzymes to release the recombination
cassette (Fig. 2). This cassette was ampli¢ed by PCR using oligonu-
cleotides 1PE and 4PE as primers. The PCR product was used to
transform electrocompetent cells of strain EcAB3-1. The cells were
plated on 2UTY medium [21] containing 17 Wg/ml chloramphenicol,
6 Wg/ml tetracycline, 25 Wg/ml kanamycin, 0.2% (w/v) L-arabinose and
1 mM MVA. The presence of the CAT gene instead of the gcpE
coding sequence in the genome of transformants was con¢rmed by
PCR using oligonucleotides 0PE and 5PE as primers. The identity of
the PCR product was veri¢ed by restriction analysis. Oligonucleotides
0PE and 5PE are complementary to sequences located outside of the
region included in the deletion construct (Fig. 2). Therefore, the anal-
ysis of transformants con¢rmed both the absence of the original gcpE
gene and the presence of the CAT gene. The novel strain lacking the
gcpE gene was named EcAB3-3 (Table 1).
3. Results and discussion
3.1. Identi¢cation of the gcpE gene
To identify genes potentially involved in the MEP pathway,
we followed a bioinformatic approach. Since bacterial genes
with related functions are often organised in operons, we ex-
amined uncharacterised open reading frames (ORFs) that are
beside known genes of the MEP pathway. An ORF of 1195
bp with unknown function was found just upstream of a DXS
coding sequence of Streptomyces coelicolor (cosmid 6A5, ac-
cession number AL049485). This ORF is homologous to the
gcpE gene of E. coli [22] and the aarC gene of Providencia
stuartii [23]. Previous data indicate that gcpE and aarC are
essential genes [22,23]. The aarC gene is required for the cell
density dependent regulation of the 2P-N-acetyltransferase, an
Fig. 1. The partial MVA pathway engineered in E. coli and the en-
dogenous MEP pathway. The intermediates of the MEP pathway
(on the left) are as follows: GA3P, glyceraldehyde 3-phosphate;
DXP, 1-deoxy-D-xylulose 5-phosphate; MEP, 2-C-methyl-D-erythri-
tol 4-phosphate; CDP-ME, 4-diphosphocytidyl-2-C-methyl-D-erythri-
tol ; CDP-ME2P, 4-diphosphocytidyl-2-C-methyl-D-erythritol 2-phos-
phate; ME-2,4cPP, 2-C-methyl-D-erythritol 2,4-cyclodiphosphate.
The genes encoding the known enzymes of the MEP pathway and
the gcpE gene are indicated. The intermediates of the engineered
mevalonate pathway (on the right) are as follows: MVA, mevalonic
acid; MVP, 5-phosphomevalonate; MVPP, 5-diphosphomevalonate.
The enzymes of the mevalonate pathway are as follows: MVK, me-
valonate kinase; PMK, 5-phosphomevalonate kinase; and PMD,
5-diphosphomevalonate decarboxylase. The idi gene encodes isopen-
tenyl diphosphate isomerase.
Table 1
E. coli strains used in this study
Strain Description
EcAB3-1 TE2680 MVA [18]; parent strain for the generation
of mutants of the MEP pathway
EcAB3-2 EcAB3-1 dxs : :CAT [18]
EcAB3-3 EcAB3-1 gcpE : :CAT
Table 2
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enzyme involved in the O acetylation of peptidoglycans. How-
ever, no precise biochemical function has been assigned so far
to the products of the aarC or the gcpE genes.
Genes with homology to gcpE are broadly distributed in
eubacteria and plants. The occurrence of the gcpE gene in
completely sequenced bacterial genomes strictly correlates
with the occurrence of the dxr gene encoding 1-deoxy-D-xylu-
lose 5-phosphate reductoisomerase, which catalyses the ¢rst
committed step in the MEP pathway (Fig. 1, Table 3). Nine-
teen out of 29 sequenced genomes contain both dxr and gcpE
genes. Ten of the sequenced genomes do not contain dxr nor
gcpE. This correlation suggested a close link between the gcpE
gene and the MEP pathway. The identity between the E. coli
gcpE gene product and the corresponding homologues of oth-
er bacteria ranges from 88.7% (P. stuartii) to 33.3% (Xylella
fastidiosa). The similarity in the equivalent comparisons
ranges from 95.2% (P. stuartii) to 54.0% (X. fastidiosa). Using
the E. coli gcpE gene product as a query and the default
parameters of the TBLASTN program accessible at the Na-
tional Center for Biotechnology Information (NCBI) (http://
www.ncbi.nlm.nih.gov/), EST entries corresponding to gcpE
homologues were detected in Arabidopsis thaliana, Glycine
max, Lycopersicon esculentum, Lycopersicon hirsutum, Medi-
cago trunculata, Physcomitrella patens, Pinus taeda, Porphyra
yezoensis, Secale cereale, Solanum tuberosum, Triticum aesti-
vum and Zea mays (data not shown). The presence of gcpE
gene homologues in plants is consistent with a role of this
gene in the MEP pathway. Also in agreement with this hy-
pothesis, no homologue of the gcpE gene is present in the
eukaryote Saccharomyces cerevisiae, in which all isoprenoids
derive from MVA (Table 3).
3.2. Deletion of the gcpE gene in E. coli
To examine whether the gcpE gene of E. coli was indeed
involved in the MEP pathway, we deleted this gene in strain
EcAB3-1 (Fig. 2). Lethal mutants of the MEP pathway can be
rescued in this strain by supplementation with MVA [18].
Conversion of MVA to IPP and DMAPP in strain EcAB3-1
and derivatives is mediated by a synthetic operon encoding
yeast 5-diphosphomevalonate decarboxylase, human 5-phos-
phomevalonate kinase, yeast mevalonate kinase and E. coli
isopentenyl diphosphate isomerase stably integrated in the
chromosome. This operon is under control of the PBAD pro-
moter which can be induced with L-arabinose. Deletion of the
gcpE gene was accomplished by homologous recombination
between the genome and the construct GC5CAT3 in which a
chloramphenicol resistance gene (CAT) is surrounded by the
gcpE £anking regions (Fig. 2). Substitution of the CAT gene
Fig. 2. Deletion of the gcpE gene in the E. coli genome. The CAT gene was substituted for the gcpE gene by homologous recombination. The
construct GC5CAT3, containing the CAT gene surrounded by the gcpE £anking regions, was recombined with the gcpE genomic region of
strain EcAB3-1. The resulting strain was named EcAB3-3. Arrowheads indicate the position of primers used to prepare the recombination con-
struct and to analyse the mutated locus. Restriction enzyme sites are indicated.
Fig. 3. Complementation of the gcpE mutant with MVA. Strains EcAB3-2 and EcAB3-3 were grown at 37‡C in 2UTY medium [21] containing
1.5% agar (w/v), 6 Wg/ml tetracycline, 25 Wg/ml kanamycin, 17 Wg/ml chloramphenicol and 0.2% (w/v) L-arabinose. MVA (1 mM) was present
in the medium as indicated.
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for the gcpE coding sequence in the genome of transformants
was con¢rmed by PCR and restriction analysis (see Section 2
for details). The E. coli strain lacking the gcpE gene was
named EcAB3-3.
As shown in Fig. 3, the presence of MVA in the medium
was required for growth of strain EcAB3-3. This metabolite
also restored growth of the control strain EcAB3-2 in which
the dxs gene, encoding the ¢rst enzyme of the MEP pathway,
was disrupted (Table 1). The result demonstrates that the
gcpE gene product is required for the operation of the MEP
pathway. The gcpE gene is essential in E. coli and is likely to
be essential as well in other bacteria in which the MEP path-
way is the only alternative for the synthesis of IPP and
DMAPP. The possibility that the gcpE gene is essential in
other bacteria and plants where the MVA and the MEP path-
ways coexist remains to be investigated. As mentioned above,
the MEP pathway is branched in E. coli (Fig. 1). It can be
concluded that the gcpE gene product is involved in the trunk
line of the MEP pathway. If the gcpE gene were required for
one of the branches alone, deletion of this gene would not be
lethal. A block produced in a single branch of the MEP path-
way would be circumvented by isopentenyl diphosphate iso-
merase [18] (Fig. 1).
The biochemical function of the gcpE gene product is pres-
ently unknown. No signi¢cant homology to other character-
ised proteins was found in databank searches using the
BLAST software accessible at the NCBI. In addition, no char-
acteristic motif that might suggest a function was found with
the PROSITE program accessible at the Expasy Molecular
Biology Server (http://www.expasy.ch/). It is possible that
the gcpE gene product has a novel catalytic activity, either
alone or in combination with other protein subunits. Alterna-
tively, the gcpE protein might have a regulatory role in the
MEP pathway. However, this possibility appears unlikely be-
cause of the broad distribution of gcpE homologues in eubac-
teria and plants. Experiments are being conducted at present
to determine the function of the gcpE gene.
Acknowledgements: We thank Dr. K. Poralla for bringing to our no-
tice the presence of a DXS coding sequence in cosmid 6A5 from
S. coelicolor. This work was supported by grants from the Spanish
Ministerio de Educacio¤n y Cultura (DGICYT, PB96-0176), the Gen-
eralitat de Catalunya (CIRIT, 1999SGR00032) and the Institut Uni-
versitaire de France.
References
[1] (1996) Dictionary of Natural Products on CD-ROM (v. 5.1),
Chapman and Hall, London.
[2] Eisenreich, W., Schwarz, M., Cartayrade, A., Arigoni, D., Zenk,
M.H. and Bacher, A. (1998) Chem. Biol. 5, R221^R233.
[3] Rohmer, M. (1999) Nat. Prod. Rep. 16, 565^574.
[4] Lichtenthaler, H.K. (1999) Annu. Rev. Plant Physiol. Plant Mol.
Biol. 50, 47^65.
[5] Sprenger, G.A., Schorken, U., Wiegert, T., Grolle, S., de Graaf,
A.A., Taylor, S.V., Begley, T.P., Bringer-Meyer, S. and Sahm, H.
(1997) Proc. Natl. Acad. Sci. USA 94, 12857^12862.
[6] Lois, L.M., Campos, N., Rosa-Putra, S., Danielsen, K., Rohmer,
M. and Boronat, A. (1998) Proc. Natl. Acad. Sci. USA 95, 2105^
2110.
[7] Takahashi, S., Kuzuyama, T., Watanabe, H. and Seto, H. (1998)
Proc. Natl. Acad. Sci. USA 95, 9879^9884.
[8] Rohdich, F., Wungsintaweekul, J., Fellermeier, M., Sagner, S.,
Herz, S., Kis, K., Eisenreich, W., Bacher, A. and Zenk, M.H.
(1999) Proc. Natl. Acad. Sci. USA 96, 11758^11763.
[9] Kuzuyama, T., Takagi, M., Kaneda, K., Dairi, T. and Seto, H.
(2000) Tetrahedron Lett. 41, 703^706.
[10] Lu«ttgen, H., Rohdich, F., Herz, S., Wungsintaweekul, J., Hecht,
S., Schuhr, C.A., Fellermeier, M., Sagner, S., Zenk, M.H., Bach-
er, A. and Eisenreich, W. (2000) Proc. Natl. Acad. Sci. USA 97,
1062^1067.
[11] Kuzuyama, T., Takagi, M., Kaneda, K., Watanabe, H., Dairi, T.
and Seto, H. (2000) Tetrahedron Lett. 41, 2925^2928.
[12] Herz, S., Wungsintaweekul, J., Schuhr, C.A., Hecht, S., Lu«ttgen,
H., Sagner, S., Fellermeier, M., Eisenreich, W., Zenk, M.H.,
Bacher, A. and Rohdich, F. (2000) Proc. Natl. Acad. Sci. USA
97, 2486^2490.
[13] Takagi, M., Kuzuyama, T., Kaneda, K., Watanabe, H., Dairi, T.
and Seto, H. (2000) Tetrahedron Lett. 41, 3395^3398.
[14] Giner, J.L., Jaun, B. and Arigoni, B. (1998) Chem. Commun. 17,
1857^1858.
[15] Leyes, A.E., Baker, J.A., Hahn, F.M. and Poulter, C.D. (1999)
Chem. Commun. 8, 717^718.
[16] Charon, L., Hoe¥er, J.F., Pale-Grosdemange, C., Lois, L.M.,
Campos, N., Boronat, A. and Rohmer, M. (2000) Biochem. J.
346, 737^742.
[17] Rodr|¤guez-Concepcio¤n, M., Campos, N., Lois, L.M., Maldona-
do, C., Hoe¥er, J.F., Grosdemange-Billiard, C., Rohmer, M.
and Boronat, A. (2000) FEBS Lett. 473, 328^332.
[18] Campos, N., Rodr|¤guez-Concepcio¤n, M., Sauret-Gu«eto, S., Gal-
lego, F., Lois, L.M. and Boronat, A. (2000) Biochem. J., in press.
[19] Casadaban, M.J. (1976) J. Mol. Biol. 104, 541^555.
[20] Fuqua, W.C. (1992) BioTechniques 12, 223^225.
[21] Ausubel, F.M., Brent, R., Kingston, R.E., Moore, D.D., Seid-
man, J.G., Smith, J.A. and Struhl, K. (1987) Short Protocols in
Molecular Biology, Wiley, New York.
[22] Baker, J., Franklin, D.B. and Parker, J. (1992) FEMS Microbiol.
Lett. 94, 175^180.
[23] Rather, P.N., Solinsky, K.A., Paradise, M.R. and Parojcic, M.M.
(1997) J. Bacteriol. 179, 2267^2273.
Table 3




Aquifex aeolicus VF5 AE000745 AE000688
Bacillus halodurans C-125 AP001511 AP001515
Bacillus subtilis 168 Z99116 Z99112
Buchnera sp. APS AP001118 A001118
Campylobacter jejuni NCTC 11168 AL139076 AL139078
Chlamydia pneumoniae CWL029 AE001621 AE001618
Chlamydia trachomatis D/UW-3/Cx AE001280 AE001281
Deinococcus radiodurans R1 AE001898 AE001994
E. coli K-12 MG1655 AE000338 AE000126
Haemophilus in£uenzae Rd KW20 U32721 U32763
Helicobacter pylori 26695 AE000577 AE000541
Mycobacterium tuberculosis H37Rv AL008883 Z74024
Neisseria meningitidis MC58 AE002479 AE002375
Pseudomonas aeruginosa PA01 AE004798 AE004785
Synechocystis sp. PCC 6803 D90908 D64000
Thermotoga maritima MSB8 AE001754 AE001754
Treponema pallidum Nichols AE001221 AE001235
Vibrio cholerae N16961 AE004161 AE004297
X. fastidiosa 9a5c AE004064 AE003942
Borrelia burgdorferi B31 ^ ^
Mycoplasma genitalium G-37 ^ ^
Mycoplasma pneumoniae M129 ^ ^
Rickettsia prowazekii Madrid E ^ ^
Archea
Aeropyrum pernix K1 ^ ^




Methanococcus jannaschii DSM2661 ^ ^
Pyrococcus abyssi GE5 ^ ^
Pyrococcus horikoshii OT3 ^ ^
Eukaryotes
S. cerevisiae S288C ^ ^
The accession numbers at the NCBI database are indicated.
aUpdated on 6th October, 2000.
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